ATE241626T1 - Kondensierte imidazolderivate als modulatoren vielfacher medikamentenresistenz - Google Patents

Kondensierte imidazolderivate als modulatoren vielfacher medikamentenresistenz

Info

Publication number
ATE241626T1
ATE241626T1 AT97908226T AT97908226T ATE241626T1 AT E241626 T1 ATE241626 T1 AT E241626T1 AT 97908226 T AT97908226 T AT 97908226T AT 97908226 T AT97908226 T AT 97908226T AT E241626 T1 ATE241626 T1 AT E241626T1
Authority
AT
Austria
Prior art keywords
modulators
drug resistance
imidazole derivatives
multiple drug
condensed imidazole
Prior art date
Application number
AT97908226T
Other languages
English (en)
Inventor
Frans Eduard Janssens
Joseph Elisabeth Leenaerts
Francois Maria Sommen
Dominique Louis Nest Surleraux
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE241626T1 publication Critical patent/ATE241626T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT97908226T 1996-03-19 1997-03-11 Kondensierte imidazolderivate als modulatoren vielfacher medikamentenresistenz ATE241626T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96200755 1996-03-19
PCT/EP1997/001264 WO1997034897A1 (en) 1996-03-19 1997-03-11 Fused imidazole derivatives as multidrug resistance modulators

Publications (1)

Publication Number Publication Date
ATE241626T1 true ATE241626T1 (de) 2003-06-15

Family

ID=8223797

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97908226T ATE241626T1 (de) 1996-03-19 1997-03-11 Kondensierte imidazolderivate als modulatoren vielfacher medikamentenresistenz

Country Status (30)

Country Link
US (3) US6218381B1 (de)
EP (1) EP0888352B1 (de)
JP (3) JP3630434B2 (de)
KR (2) KR100330698B1 (de)
CN (1) CN1083453C (de)
AR (1) AR006271A1 (de)
AT (1) ATE241626T1 (de)
BG (1) BG62734B1 (de)
BR (1) BR9708140A (de)
CA (1) CA2237594C (de)
CZ (1) CZ294060B6 (de)
DE (1) DE69722389T2 (de)
EA (1) EA001004B1 (de)
EE (1) EE03773B1 (de)
ES (1) ES2200159T3 (de)
HK (1) HK1015769A1 (de)
HR (1) HRP970161B1 (de)
HU (1) HU224528B1 (de)
ID (1) ID16375A (de)
IL (1) IL124572A (de)
MX (1) MX9804426A (de)
MY (1) MY118282A (de)
NO (1) NO310659B1 (de)
NZ (1) NZ330466A (de)
PL (1) PL193444B1 (de)
SK (1) SK284434B6 (de)
TR (1) TR199801191T2 (de)
TW (1) TW527186B (de)
WO (1) WO1997034897A1 (de)
ZA (1) ZA972351B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544979B1 (en) 1997-09-18 2003-04-08 Janssen Pharmaceuticals, N.V. Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents
WO1999049848A1 (en) * 1998-04-01 1999-10-07 Rtp Pharma Inc. Anticancer compositions
US6743794B2 (en) 1999-12-22 2004-06-01 Eli Lilly And Company Methods and compounds for inhibiting MRP1
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
EP1401838B1 (de) 2001-06-12 2014-03-26 Janssen Pharmaceutica NV Substituierte tetrazyklische imidazol derivate, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen sie einthaltend und ihre verwendung als arzneimittel
NZ550723A (en) * 2001-11-23 2008-06-30 Janssen Pharmaceutica Nv The use of anti-histaminics for acute reduction of elevated intracranial pressure
GB0301736D0 (en) * 2003-01-24 2003-02-26 Xenova Ltd Pharmaceutical compounds
EP2978765B1 (de) * 2013-03-25 2018-05-02 Crystal Pharma S.A.U Verfahren zur herstellung von alcaftadin
CN103408549B (zh) * 2013-06-14 2016-01-20 苏州汇和药业有限公司 一种阿卡他定中间体的制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2418502C3 (de) * 1974-04-11 1980-04-24 Schering Ag, 1000 Berlin Und 4619 Bergkamen Dichlorbenzyl- [2-( a -imidazolylbutyl)-phenyl] -äther und -thioäther, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4153719A (en) * 1977-09-06 1979-05-08 Sterling Drug Inc. Aromatic diketones
JPS56125326A (en) * 1980-03-07 1981-10-01 Asahi Kagaku Kogyo Kk Preparation of chlorinated phenoxytoluenes in high selectivity
US4794188A (en) 1982-12-01 1988-12-27 Usv Pharmaceutical Corporation Certain unsymmetrical quinolinyl ethers having anti-inflammatory and anti-allergic activity
US4778931A (en) 1982-12-01 1988-10-18 Usv Pharmaceutical Corporation Certain [3-(1-hydroxy hexyl-tetrahydro)naphthalenes], the corresponding naphthalenes having anti-inflammatory and anti-allergic activity
US4567184A (en) 1982-12-01 1986-01-28 Usv Pharmaceutical Corporation Certain aryl or hetero-aryl derivatives of 1-hydroxy-pentane or 1-hydroxy-hexane which are useful for treating inflammation and allergies
US4588722A (en) 1984-01-09 1986-05-13 Janssen Pharmaceutica N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives
JPS61151176A (ja) * 1984-12-24 1986-07-09 Sumitomo Chem Co Ltd ベンズイミダゾール誘導体およびそれを有効成分とする殺虫、殺ダニ剤
US4631287A (en) * 1985-04-16 1986-12-23 Usv Pharmaceutical Corp. Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
AU7100887A (en) * 1986-04-07 1987-10-08 Sumitomo Chemical Company, Limited Halogenated aromatic ethers and alcohol and aldehyde intermediates
JPS6475441A (en) * 1987-09-16 1989-03-22 Sumitomo Chemical Co Production of optically active ether compound
JPH01254680A (ja) * 1988-04-01 1989-10-11 Sumitomo Chem Co Ltd 複素環化合物、その製造法およびそれを有効成分とする殺菌剤
DE69110685T2 (de) * 1990-10-10 1995-11-09 Schering Corp Substituierte imidazobenzazepine und imidazopyridoazepine.
IL101850A (en) 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv History 11-) 4-Pipridinyl (-Imidazo] B-1, 2 [] 3 [Benzazepine, their preparation and pharmaceutical preparations containing them
IL101851A (en) 1991-06-13 1996-05-14 Janssen Pharmaceutica Nv History 01 -) 4 - Pipridinyl - and Pipridinylidene (- Imidazo] A-1,2 [Pirolo, Thiano or Purano (] 3,2 [Azpin, their preparation and pharmaceutical preparations containing them and composition
GB9122590D0 (en) * 1991-10-24 1991-12-04 Lilly Industries Ltd Pharmaceutical compounds
DE69325805T2 (de) 1992-02-06 2000-03-16 Merrell Pharma Inc Umkehr der mehrfachresistenz gegen medikamente durch triphenyl-piperidin derivate
US5629308A (en) 1992-12-04 1997-05-13 Janssen Pharmaceutica N.V. Imidazo [1,2-A] (pyrrolo, thieno or furano) [2,3-D] azepine derivatives
DE69425882T2 (de) 1993-03-29 2001-01-11 Basf Ag 1-amino-3-phenoxy-propan-derivate als modulatoren bei multi-drug resistenz
ATE198480T1 (de) 1993-07-13 2001-01-15 Janssen Pharmaceutica Nv Antiallergische imidazoazepine
US5486612A (en) * 1993-12-14 1996-01-23 Eli Lilly And Company N-benzyl dihydroindole LTD4 antagonists
US5596008A (en) * 1995-02-10 1997-01-21 G. D. Searle & Co. 3,4-Diaryl substituted pyridines for the treatment of inflammation
FR2731708B1 (fr) 1995-03-13 1997-04-30 Synthelabo Derives de piperidine, leur procede de preparation et leur application en therapeutique
TW382017B (en) 1995-12-27 2000-02-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives

Also Published As

Publication number Publication date
EP0888352A1 (de) 1999-01-07
KR100330698B1 (ko) 2002-10-31
CN1211985A (zh) 1999-03-24
HUP9900415A3 (en) 2001-11-28
US6218381B1 (en) 2001-04-17
MY118282A (en) 2004-09-30
BG102459A (en) 1999-06-30
HRP970161B1 (en) 2002-06-30
CN1083453C (zh) 2002-04-24
PL193444B1 (pl) 2007-02-28
DE69722389D1 (de) 2003-07-03
AU2026997A (en) 1997-10-10
NO982124D0 (no) 1998-05-11
KR20000064358A (ko) 2000-11-06
MX9804426A (es) 1998-09-30
EE03773B1 (et) 2002-06-17
NZ330466A (en) 1999-03-29
DE69722389T2 (de) 2009-09-24
TR199801191T2 (xx) 1998-10-21
PL327985A1 (en) 1999-01-04
CZ294060B6 (cs) 2004-09-15
ID16375A (id) 1997-09-25
SK284434B6 (sk) 2005-04-01
US6476018B1 (en) 2002-11-05
NO310659B1 (no) 2001-08-06
ES2200159T3 (es) 2004-03-01
IL124572A0 (en) 1998-12-06
JP4205319B2 (ja) 2009-01-07
TW527186B (en) 2003-04-11
EE9800281A (et) 1999-02-15
JP2004067701A (ja) 2004-03-04
ZA972351B (en) 1998-09-18
JP2000505477A (ja) 2000-05-09
AU709683B2 (en) 1999-09-02
EA001004B1 (ru) 2000-08-28
BR9708140A (pt) 1999-07-27
US20030087895A1 (en) 2003-05-08
AR006271A1 (es) 1999-08-11
HU224528B1 (hu) 2005-10-28
CZ152998A3 (cs) 1999-02-17
HRP970161A2 (en) 1998-04-30
JP4251447B2 (ja) 2009-04-08
NO982124L (no) 1998-09-18
HK1015769A1 (en) 1999-10-22
IL124572A (en) 2002-03-10
EP0888352B1 (de) 2003-05-28
CA2237594A1 (en) 1997-09-25
KR100349500B1 (ko) 2002-08-21
EA199800586A1 (ru) 1998-12-24
SK66298A3 (en) 1999-06-11
JP2002012594A (ja) 2002-01-15
CA2237594C (en) 2006-05-30
JP3630434B2 (ja) 2005-03-16
WO1997034897A1 (en) 1997-09-25
HUP9900415A2 (hu) 1999-05-28
BG62734B1 (bg) 2000-06-30

Similar Documents

Publication Publication Date Title
DE69712331D1 (de) Pyrimidin-4-on derivate als pestizidesmittel
PT892640E (pt) Composicoes farmaceuticas de micofenolato entericamente revestidas
PT1019090E (pt) Derivados polimeros de camptotecina
DE69613368D1 (de) Chinazolin derivate
DE69613369T2 (de) Chinazolin derivate
DE69613367D1 (de) Chinazolin derivate
BR9707910A (pt) Unidade de equilíbrio
DE59813222D1 (de) Kathetersystem
EE9900211A (et) Asendatud pürasooliderivaadid
ID19343A (id) Alat penghirup bubuk obat
DE69713284D1 (de) Triazol-Derivate als Arzneimittel
DE69825987D1 (de) Kathetersystem
DE69605430T2 (de) Chinolin-2-on derivate als serotonin antagonisten
DE69628334D1 (de) Chinolin derivate als nk3 antagoniste
DE69719547D1 (de) Parasitizide pyrazolderivate
ATE302192T1 (de) Trizyklische pyrol- oder pyrazolderivate
DE69841138D1 (de) Imidazolderivate als mdr-modulatoren
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
ATE241626T1 (de) Kondensierte imidazolderivate als modulatoren vielfacher medikamentenresistenz
ATE224891T1 (de) Chromon-derivate
PT931087E (pt) Novos derivados de piranosido
BR9709497A (pt) Novos derivados de pirrol
ATE187165T1 (de) Benzophenonhydrazon-derivate als insektizide
NO975811D0 (no) Ny anvendelse for pyrrolderivater
DE29802977U1 (de) Pankratisches System

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
EEIH Change in the person of patent owner